The Blue Box Biomedical Solutions

📍 Barcelona, Spain🗓 Founded 2021👥 15 employees💰 Last funded Oct 2025
Medical Equipment Manufacturing🌐 thebluebox.ai
Website LinkedIn
Breast cancer is the most treatable cancer, yet it remains the leading cause of death by cancer in women—largely because national screening programs miss up to 1 in 3 cases. The problem is even worse for women with dense breasts, who make up 50% of the screening population and for whom mammography is less reliable. At The Blue Box, weve developed a urine-based breast cancer test with a sensitivity of 88.42%, outperforming mammography by 15% overall—and by 30% in women with dense breasts. Were launching clinical trials in 2025 and bringing our test to gynecology clinics by 2026.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Ireland
1
Frequently asked questions
Who invested in The Blue Box Biomedical Solutions?
The Blue Box Biomedical Solutions has 1 investors on record on gritt.io, 1 mid-stage.
When did The Blue Box Biomedical Solutions last raise funding?
The most recent investment in The Blue Box Biomedical Solutions recorded on gritt.io was in October 2025.
When was The Blue Box Biomedical Solutions founded?
The Blue Box Biomedical Solutions was founded in 2021.
What industry is The Blue Box Biomedical Solutions in?
The Blue Box Biomedical Solutions operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is The Blue Box Biomedical Solutions based?
The Blue Box Biomedical Solutions is headquartered in Barcelona, Spain.